Igaunija -
igauņu -
Ravimiamet
mirtazapin actavis suus dispergeeruv tablett
teva b.v. - mirtasapiin - suus dispergeeruv tablett - 15mg 96tk; 15mg 50tk; 15mg 180tk; 15mg 6tk; 15mg 48tk; 15mg 100tk
Igaunija -
igauņu -
Ravimiamet
mirtazapin actavis suus dispergeeruv tablett
teva b.v. - mirtasapiin - suus dispergeeruv tablett - 30mg 90tk; 30mg 96tk; 30mg 48tk; 30mg 50tk; 30mg 180tk; 30mg 100tk; 30mg 30tk
Eiropas Savienība -
igauņu -
EMA (European Medicines Agency)
pedmarqsi
fennec pharmaceuticals (eu) limited - sodium thiosulfate - ear diseases; ototoxicity - kõik muud ravitoimingud - pedmarqsi is indicated for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to < 18 years of age with localised, non-metastatic, solid tumours.